LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 5 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 2. - Dataset (ID:20313)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.00 | 19.50 | 748 | 4146 | 0.1805 | 0.3769 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 48.00 | 19.50 | 771 | 4441 | 0.1734 | 0.3839 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 50.00 | 19.50 | 805 | 4744 | 0.1691 | 0.3934 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.90 | 19.50 | 830 | 4974 | 0.1660 | 0.3947 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.90 | 19.50 | 849 | 5154 | 0.1636 | 0.4089 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 55.90 | 19.50 | 887 | 5348 | 0.1642 | 0.3940 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 57.80 | 19.50 | 909 | 5483 | 0.1643 | 0.3961 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 59.80 | 19.50 | 940 | 5578 | 0.1670 | 0.4131 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 62.80 | 19.50 | 975 | 5586 | 0.1730 | 0.4206 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 64.70 | 19.50 | 1012 | 5643 | 0.1782 | 0.4508 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 66.70 | 19.50 | 1041 | 5728 | 0.1807 | 0.4535 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 68.70 | 19.50 | 1032 | 5743 | 0.1793 | 0.4521 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 70.70 | 19.50 | 1106 | 5784 | 0.1901 | 0.4589 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 72.60 | 19.50 | 1123 | 5854 | 0.1910 | 0.4607 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 74.60 | 19.50 | 1147 | 5927 | 0.1927 | 0.4475 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 76.60 | 19.50 | 1175 | 5898 | 0.1987 | 0.4638 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 78.50 | 19.50 | 1197 | 5949 | 0.2006 | 0.4709 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 80.50 | 19.50 | 1173 | 6018 | 0.1947 | 0.4602 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 82.50 | 19.50 | 1257 | 6031 | 0.2079 | 0.4622 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 84.40 | 19.50 | 1275 | 6038 | 0.2110 | 0.4739 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 86.40 | 19.50 | 1301 | 6081 | 0.2137 | 0.4641 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 88.40 | 19.50 | 1332 | 6064 | 0.2196 | 0.4694 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 90.40 | 19.50 | 1360 | 6097 | 0.2232 | 0.4827 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 92.30 | 19.50 | 1378 | 6153 | 0.2242 | 0.4801 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 94.30 | 19.50 | 1406 | 6154 | 0.2288 | 0.4672 |